Novavax Confirms European Medicines Agency Review of COVID-19 ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., Nov. 18, 2021 /PRNewswire-AsiaNet/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that European Medicines Agency (EMA) has begun its evaluation of an applica...
Authors: LATEST ASIANET NEWS RELEASES